Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA3 | P07451 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19145906 | 0.94 | LMNA (0.39) | LMNACA12CA1CA2CA3 | |
| SCHEMBL11734817 | 0.88 | LMNA (0.40) | LMNACA12CA1CA2CA3 | |
| SCHEMBL6936145 | 0.85 | LMNA (0.47) | LMNACA12CA1CA2CA3 | |
| SCHEMBL15909726 | 0.83 | LMNA (0.41) | LMNACA12CA1CA2CA3 | |
| SCHEMBL11734829 | 0.82 | LMNA (0.40) | LMNACA12CA1CA2CA3 | |
| SCHEMBL2036449 | 0.81 | KMT2A (0.43) | LMNACA12CA1CA2CA3 | |
| SCHEMBL15909729 | 0.81 | TSHR (0.46) | LMNACA12CA1CA2CA3 | |
| SCHEMBL1817230 | 0.80 | ALDH1A1 (0.44) | LMNACA12CA1CA2CA3 | |
| SCHEMBL8854339 | 0.80 | LMNA (0.41) | LMNACA12CA1CA2CA3 | |
| SCHEMBL6935129 | 0.80 | LMNA (0.42) | LMNACA12CA1CA2CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114478942-A | Polycarboxylate superplasticizer capable of effectively resisting influence of flocculating agent and preparation method thereof | 四川同舟化工科技有限公司 | 2022-05-13 | — | — | CN | claimed |
| US-20180327628-A1 | COATING COMPOSITIONS FOR FORMING TONER COATINGS | ISP INVESTMENTS LLC (US) | 2018-11-15 | — | — | US | claimed |
| US-11912831-B2 | Hydroxyethylpyrrolidone ethacrylate/glycidyl ethacrylate copolymers | ISP INVESTMENTS LLC (US) | 2024-02-27 | — | — | US | disclosed |
| US-11912831-B2 | Hydroxyethylpyrrolidone ethacrylate/glycidyl ethacrylate copolymers | ISP INVESTMENTS LLC (US) | 2024-02-27 | — | — | US | disclosed |
| US-11859029-B2 | Methods of synthesis of homopolymers and non-homopolymers comprising repeating units derived from monomers comprising lactam and acryloyl moieties in an aqueous medium | ISP INVESTMENTS LLC (US) | 2024-01-02 | — | — | US | disclosed |
| CN-114478942-A | Polycarboxylate superplasticizer capable of effectively resisting influence of flocculating agent and preparation method thereof | 四川同舟化工科技有限公司 | 2022-05-13 | — | — | CN | disclosed |
| CN-114478942-A | Polycarboxylate superplasticizer capable of effectively resisting influence of flocculating agent and preparation method thereof | 四川同舟化工科技有限公司 | 2022-05-13 | — | — | CN | disclosed |
| US-11001751-B2 | Crosslinked polymers derived from monomers having acryloyl and lactam moieties and sulfonic acid/sulfonate comonomers, compositions thereof, and applications thereof | HERCULES LLC (US) | 2021-05-11 | — | — | US | disclosed |
| US-10905636-B2 | Block copolymers comprising repeating units derived from monomers comprising lactam and acryloyl moieties and hydrophobic monomers, compositions, and applications thereof | ISP INVESTMENTS LLC (US) | 2021-02-02 | — | — | US | disclosed |
| US-20200407470-A1 | METHODS OF SYNTHESIS OF HOMOPOLYMERS AND NON-HOMOPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES IN AN AQUEOUS MEDIUM | ISP INVESTMENTS LLC (US) | 2020-12-31 | — | — | US | disclosed |
| US-10876015-B2 | Coating compositions for forming toner coatings | ISP INVESTMENTS LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-6132462-A | HYDROXYALKYL (ALKYL)ACRYLATE; PYRROLIDONE-CONTAINING ACRYLIC ESTER, AMIDE, OR IMIDE; AND A LOWER ALKYL (ALKYL)ACRYLATE TERPOLYMER; FOLDABLE LENSE HAVING GIVEN REFRACTIVE INDEX, RECOVERY SPEED FROM FOLD STATE AND TENSILE STRENGTH | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2000-10-17 | — | — | US | disclosed |
| EP-1026182-A1 | FOUR COMPONENT COPOLYMER AND THE OCULAR LENS MADE THEREOF | SANTEN PHARMACEUTICAL CO., LTD (JP) | 2000-08-09 | — | — | EP | disclosed |
| EP-0987247-A1 | ITACONATE DERIVATIVES USED FOR A COMPONENT OF A POLYMER | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2000-03-22 | — | — | EP | disclosed |
| CN-1213671-A | Four-component copolymer and eye lens formed by same | SANTEN PHARMACEUTICAL CO LTD (JP) | 1999-04-14 | — | — | CN | disclosed |
| EP-0869138-A1 | NOVEL COPOLYMERS FORMED FROM THREE COMPONENTS AND INTRAOCULAR LENSES MADE THEREOF | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1998-10-07 | — | — | EP | disclosed |
| CN-1152584-A | Three constituents copolymer and eye lens made from it | SANTEN PHARMACEUTICAL CO LTD (JP) | 1997-06-25 | — | — | CN | disclosed |
| US-5629359-A | OXO-PYRROLIDINYL (METH)ACRYLIC ESTER | U C B S.A. (BE) | 1997-05-13 | — | — | US | disclosed |
| US-5188770-A | Polyalkyl (meth)acrylates as oil additives | Rphm GmbH (DE) | 1993-02-23 | — | — | US | disclosed |
| US-3968148-A | Copolymers of 1-alkenes and acrylic acid derivatives | ROHM AND HAAS COMPANY (US) | 1976-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11912831-B2 | Hydroxyethylpyrrolidone ethacrylate/glycidyl ethacrylate copolymers | MMAB, PCNA, HMBS | LMNA 2499/4885CA12 1204/4885CA1 867/4885 |
| US-10905636-B2 | Block copolymers comprising repeating units derived from monomers comprising lactam and acryloyl moieties and hydrophobic monomers, compositions, and applications thereof | F9, ADCY9, MMS19 | LMNA 2191/4885CA12 2531/4885CA1 3645/4885 |
| US-11001751-B2 | Crosslinked polymers derived from monomers having acryloyl and lactam moieties and sulfonic acid/sulfonate comonomers, compositions thereof, and applications thereof | CAD, STS, COASY | LMNA 1683/4885CA12 1078/4885CA1 296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.